IDT Australia Ltd
ASX:IDT
IDT Australia Ltd
ASX:IDT
Price:
0.0925 AUD
1.65%
Market Closed
Updated:
May 3, 2024
IDT Australia Ltd
Cash from Financing Activities
|
IDT Australia Ltd
Cash from Financing Activities Peer Comparison
Comparables:
MYX
NEU
BOT
PBP
C
CU6
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
IDT Australia Ltd
ASX:IDT
|
Cash from Financing Activities
AU$3.6m
|
CAGR 3-Years
156%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-5%
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Financing Activities
-AU$431.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Financing Activities
AU$3.6m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-18%
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Cash from Financing Activities
AU$36.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
46%
|
|
|
Probiotec Ltd
ASX:PBP
|
Cash from Financing Activities
-AU$11.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Financing Activities
AU$231.6k
|
CAGR 3-Years
-70%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is IDT Australia Ltd's Cash from Financing Activities?
Cash from Financing Activities
3.6m
AUD
3.6m
AUD
Based on the financial report for Dec 31, 2023, IDT Australia Ltd's Cash from Financing Activities amounts to 3.6m AUD.
What is IDT Australia Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-5%
-5%
The average annual Cash from Financing Activities growth rates for IDT Australia Ltd have been 156% over the past three years , and -5% over the past ten years .
You don't have any saved screeners yet
